510(k) Report

510(k) · Cleared

Cleared

Helios+ UV-C System

K242604510(k) TraditionalCleared May 27, 2025270-day reviewClass II21 CFR 880.6510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Preventamed Technologies, Inc. Dba Surfacide Manufacturing · QXJ Whole Room Microbial Reduction Device

Cleared on May 27, 2025 as substantially equivalent to DEN230007 (Xenex Disinfection Services, Inc., 2023) after a 270-day review. Its family tree reaches back 1 generation to 2023.

Decided
May 27, 2025
Review
270 days
Class
Class II
Product code
QXJ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN230007 (2023). No later device cites it as a predicate yet.

DEN230007 · LightStrike+ (MXSUV1-SL and MXSUV1-FT) · Xenex Disinfection Services, Inc. · 20232020202220242026
  1. Root · 1 generation backDEN230007 LightStrike+ (MXSUV1-SL and MXSUV1-FT)Xenex Disinfection Services, Inc. · 2023
  2. This deviceK242604 Helios+ UV-C SystemPreventamed Technologies, Inc. Dba Surfacide Manufacturing · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN230007LightStrike+ (MXSUV1-SL and MXSUV1-FT)Xenex Disinfection Services, Inc.2023—
0 (this device)K242604Helios+ UV-C SystemPreventamed Technologies, Inc. Dba Surfacide Manufacturing2025—
FIG. 1 — Lineage of K242604, 2023–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QXJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN230007LightStrike+ (MXSUV1-SL and MXSUV1-FT)
Summary page 5
…e Device 21 CFR 807.92(a)(3) Predicate # DEN230007 Predicate Trade Name LightStrikeTM+ Product Code QXJ DEN230007…
Xenex Disinfection Services, Inc.2023—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All QXJ devices

QXJ Whole Room Microbial Reduction Device: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · QXJ

1in 2025

2023: 12025: 1
2007high 1 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QXJ

Too few QXJ 510(k)s in any year since 2007 to give a median.

Recalls per year · QXJ

No recall names QXJ since 2007.

Adverse event reports per year · QXJ

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2025

MAUDE reports naming product code QXJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20231—00
20240—00
20251—01
20260—0—

What is it indicated for?

Helios+ is a 253.7nm wavelength, high intensity, germicidal UV-C light system intended to perform microbial reduction on non-porous, non-critical medical device surfaces, free from visual soiling, after manual cleaning and disinfection practices. Helios+ is intended for use in unoccupied operating rooms, hospital rooms and other clinical settings where non-critical medical devices are present as an adjunct to existing manual cleaning and disinfection practices. The system is for over-the-counter (OTC) use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K242604: Helios+ UV-C System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K242604

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026